查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1612238

人工授精市場：按產品類型、捐贈者類型、技術、最終用戶分類 - 全球預測 2025-2030

Artificial Insemination Market by Product (Accessories, Home Conception Devices, Insemination Kits), Donor Type (Fresh Donor Semen, Frozen Donor Semen), Technique, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年人工授精市場價值為31.7億美元，預計到2024年將達到34.2億美元，複合年成長率為8.16%，到2030年將達到54.9億美元。

人工授精（AI）是生殖醫學和動物繁殖中的重要技術，涉及將精液有意引入女性生殖道。這種方法不需要自然繁殖，提高了繁殖效率和遺傳多樣性。需要人工智慧的主要原因是整個畜牧業的遺傳改良、提高繁殖成功率和疾病控制。它已廣泛應用於牛、豬、家禽，最近又應用於水產養殖。在人類領域，人工智慧已成為不孕症治療的重要解決方案。人工智慧的最終用途包括尋求有效生殖方法的農業公司到提供輔助生殖技術的醫療機構。就市場洞察而言，人工智慧市場的成長受到技術進步、不孕症現象的增加以及肉類和酪農生產需求不斷成長的顯著影響。人們對動物健康和生殖品質的認知不斷提高，從而提高了收養率。然而，道德問題、先進技術的高成本以及跨地區監管標準不匹配等挑戰可能會阻礙市場擴張。人工智慧應用在新興經濟體的擴展以及低溫保存和基因檢測等人工智慧技術的使用可以顯著改善結果和採用率，創造潛在的商機。專注於開發適合小型農場的低成本、高效的人工智慧解決方案可以刺激需求，特別是在開發中國家。在技​​術創新方面，企業可以專注於改善人工智慧技術，提高精液分析和沈澱技術的準確性，確保更高的成功率。此外，整合人工智慧和物聯網等數位解決方案可增強對育種記錄和動物健康的監控和維護，推動市場邁向智慧農業和精準醫療。總體而言，市場呈現出動態特徵，在潛在的社會經濟和監管挑戰中，技術進步和育種方法全球化方面存在巨大的成長機會。

主要市場統計
基準年[2023] 31.7億美元
預計年份 [2024] 34.2億美元
預測年份 [2030] 54.9億美元
複合年成長率（%） 8.16%

市場動態：揭示快速發展的人工授精市場的關鍵市場洞察

供需的動態交互作用正在改變人工授精市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 世界各地的男性不孕症正在增加，導致懷孕變得困難。
    • 擴大世界各地的生育診所和醫院
    • 政府努力改善生殖健康並擴大生育治療的機會
  • 市場限制因素
    • 進行人工授精的複雜性和缺乏熟練人員
  • 市場機會
    • 提高人工授精程序準確性和成功率的進展
    • 核准家庭不孕症套件和新的人工授精解決方案
  • 市場挑戰
    • 人工授精的倫理問題與安全問題

波特五力：駕馭人工授精市場的策略工具

波特的五力架構是了解人工授精市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更具彈性的市場定位。

PESTLE分析：了解人工授精市場的外部影響

外部宏觀環境因素對人工授精市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解人工授精市場的競爭狀況

對人工授精市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣人工授精市場廠商績效評估

FPNV定位矩陣是評估人工授精市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了人工授精市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，人工授精市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的男性不孕症正在增加，導致懷孕變得困難。
      • 生育診所和醫院正在世界各地擴張
      • 政府努力改善生殖健康並擴大人工授精的機會
    • 抑制因素
      • 進行人工授精的複雜性和缺乏熟練人員
    • 機會
      • 提高人工授精程序準確性和成功率的進展
      • 核准家庭不孕症套件和新的人工授精解決方案
    • 任務
      • 與人工授精相關的倫理問題與安全問題
  • 市場區隔分析
    • 產品：家用施肥裝置越來越受歡迎，因為它們提供更大的舒適度和便利性
    • 捐贈者類型：改善冷凍捐贈者精液儲存條件和保存性的進展
    • 技術：持續研究以提高宮內授精成功率
    • 服務供應商：IVF 中心提供豐富的生育服務和患者照護的能力。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章人工授精市場：依產品

  • 配件
  • 居家受孕裝置
  • 人工授精套件

第7章依捐贈者類型分類的人工授精市場

  • 新鮮捐贈精液
  • 冷凍精液

第8章人工授精市場：依技術分類

  • 子宮頸內人工授精
  • 輸卵管內授精
  • 子宮內人工授精
  • 陰道內人工授精

第9章人工授精市場：依最終用戶分類

  • 婦科門診
  • 醫院
  • 體外受精中心
  • 婦產科醫院

第10章美洲人工授精市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區人工授精市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲人工授精市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Mosie Baby 家用人工授精套件首次獲得 510(k)核准
    • Femasys Inc. 的創新不孕症治療解決方案「FemaSeed」獲得美國FDA 上市批准
  • 戰略分析和建議

公司名單

  • Conceivex Inc.
  • Femasys Inc.
  • Fujifilm Irvine Scientific
  • Hamilton Thorne
  • IMV Technologies
  • INVO Bioscience
  • Mosie Baby
  • Pride Angel
  • Rinovum Women's Health Company
  • Vitrolife AB
Product Code: MRR-A37FCEE11759

The Artificial Insemination Market was valued at USD 3.17 billion in 2023, expected to reach USD 3.42 billion in 2024, and is projected to grow at a CAGR of 8.16%, to USD 5.49 billion by 2030.

Artificial insemination (AI) is a significant technology in reproductive medicine and animal breeding, involving the deliberate introduction of semen into a female's reproductive tract. This method increases reproductive efficiency and genetic diversity without requiring natural mating. AI is necessitated primarily by the need for genetic improvement, increased reproductive success, and disease control across livestock industries. It is applied significantly in cattle, swine, poultry, and increasingly in aquaculture. In the human context, AI serves as a crucial solution for infertility treatments. The end-use scope of AI spans from agricultural enterprises seeking efficient breeding practices to healthcare facilities providing assisted reproductive techniques. As for market insights, the AI market growth is heavily influenced by technological advancements, rising incidences of infertility, and growing demands in meat and dairy production. There's an upsurge in awareness about animal health and breeding quality, fueling adoption rates. However, challenges such as ethical concerns, high costs of advanced technology, and inconsistent regulatory standards across regions can impede market expansion. Potential opportunities arise from expanding AI applications in emerging economies and leveraging AI techniques like cryopreservation and genetic testing, which can significantly enhance outcomes and adoption rates. Emphasis on developing low-cost, efficient AI solutions tailored for small-scale farms can spur demand, particularly in developing nations. For innovation, businesses can focus on improving AI technologies to increase accuracy in semen analysis and deposition techniques, ensuring higher success rates. Furthermore, integrating digital solutions like AI and IoT can enhance monitoring and maintenance of breeding records and animal health, pushing the market towards smart farming and precision medicine. Overall, the market exhibits a dynamic nature with opportunities for substantial growth in technological advancements and globalization of breeding practices amidst underlying socio-economic and regulatory challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 3.17 billion
Estimated Year [2024] USD 3.42 billion
Forecast Year [2030] USD 5.49 billion
CAGR (%) 8.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Insemination Market

The Artificial Insemination Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of male fertility issues across the world and difficulties in conceiving
    • Expansion of fertility clinics and hospitals across the world
    • Government initiatives to improve reproductive health and expand access to artificial insemination
  • Market Restraints
    • Complexities in conducting artificial insemination and lack of skilled personnel
  • Market Opportunities
    • Advancements to improve the accuracy and success rate of artificial insemination procedures
    • Approvals for at-home fertility kits and novel artificial insemination solutions
  • Market Challenges
    • Ethical issues and safety concerns related to artificial insemination

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Insemination Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Insemination Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Insemination Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Insemination Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Insemination Market

A detailed market share analysis in the Artificial Insemination Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Insemination Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Insemination Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Insemination Market

A strategic analysis of the Artificial Insemination Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Insemination Market, highlighting leading vendors and their innovative profiles. These include Conceivex Inc., Femasys Inc., Fujifilm Irvine Scientific, Hamilton Thorne, IMV Technologies, INVO Bioscience, Mosie Baby, Pride Angel, Rinovum Women's Health Company, and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the Artificial Insemination Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Home Conception Devices, and Insemination Kits.
  • Based on Donor Type, market is studied across Fresh Donor Semen and Frozen Donor Semen.
  • Based on Technique, market is studied across Intracervical Insemination, Intratubal Insemination, Intrauterine Insemination, and Intravaginal Insemination.
  • Based on End-User, market is studied across Gynecology Clinics, Hospitals, IVF Centers, and Maternity Homes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of male fertility issues across the world and difficulties in conceiving
      • 5.1.1.2. Expansion of fertility clinics and hospitals across the world
      • 5.1.1.3. Government initiatives to improve reproductive health and expand access to artificial insemination
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in conducting artificial insemination and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements to improve the accuracy and success rate of artificial insemination procedures
      • 5.1.3.2. Approvals for at-home fertility kits and novel artificial insemination solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues and safety concerns related to artificial insemination
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing preference for home conception devices to achieve higher comfort and convenience
    • 5.2.2. Donor Type: Advancements to improve storage conditions and preservation of frozen donor semen
    • 5.2.3. Technique: Ongoing research initiatives to improve the success of intrauterine insemination
    • 5.2.4. Service Provider: Ability of IVF centers to provide a plethora of fertility services and patient care
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Insemination Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Home Conception Devices
  • 6.4. Insemination Kits

7. Artificial Insemination Market, by Donor Type

  • 7.1. Introduction
  • 7.2. Fresh Donor Semen
  • 7.3. Frozen Donor Semen

8. Artificial Insemination Market, by Technique

  • 8.1. Introduction
  • 8.2. Intracervical Insemination
  • 8.3. Intratubal Insemination
  • 8.4. Intrauterine Insemination
  • 8.5. Intravaginal Insemination

9. Artificial Insemination Market, by End-User

  • 9.1. Introduction
  • 9.2. Gynecology Clinics
  • 9.3. Hospitals
  • 9.4. IVF Centers
  • 9.5. Maternity Homes

10. Americas Artificial Insemination Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Artificial Insemination Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Insemination Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Mosie Baby receives first 510(k) clearance for at-home artificial insemination kit
    • 13.3.2. Femasys Inc. Receives U.S. FDA Clearance to Market FemaSeed, an Innovative Infertility Treatment Solution
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Conceivex Inc.
  • 2. Femasys Inc.
  • 3. Fujifilm Irvine Scientific
  • 4. Hamilton Thorne
  • 5. IMV Technologies
  • 6. INVO Bioscience
  • 7. Mosie Baby
  • 8. Pride Angel
  • 9. Rinovum Women's Health Company
  • 10. Vitrolife AB

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INSEMINATION MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL INSEMINATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ARTIFICIAL INSEMINATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ARTIFICIAL INSEMINATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INSEMINATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL INSEMINATION MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOME CONCEPTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY FRESH DONOR SEMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY FROZEN DONOR SEMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRATUBAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRAVAGINAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY GYNECOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY IVF CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY MATERNITY HOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. ARTIFICIAL INSEMINATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. ARTIFICIAL INSEMINATION MARKET, FPNV POSITIONING MATRIX, 2023